Baseline neutrophil-to-lymphocyte ratio and absolute lymphocyte count in patients with HER2-negative breast cancer treated with eribulin may predict overall survival.

被引：0
|
作者：
Maeda, Shigeto
Anan, Keisei
Koga, Kenichiro
Kuba, Sayaka
Yano, Hiroshi
Kai, Yuichiro
Nishimura, Reiki
Toh, Uhi
Yamaguchi, Miki
Mashino, Kohjiro
Mitsuyama, Shoshu
Tamura, Kazuo
Tanaka, Toshihiro
Iwase, Hirotaka
机构：
[1] Natl Hosp Org Nagasaki Med Ctr, Omura, Japan
[2] Kitakyushu Municipal Med Ctr, Kitakyushu, Fukuoka, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaski, Japan
[4] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan
[5] Ueo Breast Canc Hosp, Oita, Japan
[6] Kumamoto Shinto Gen Hosp, Breast Ctr, Kumamoto, Japan
[7] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka, Japan
[8] JCHO Kurume Gen Hosp, Kurume, Fukuoka, Japan
[9] Oita Prefectural Hosp, Oita, Japan
[10] Kitakyushu Municipal Medcl Ctr, Kitakyushu, Fukuoka, Japan
[11] Fukuoka Univ, Sch Med, Dept Internal Med, Div Oncol Hematol & Infect Dis, Fukuoka, Japan
[12] Fukuoka Univ, Dept Internal Med, Div Oncol Hematol & Infect Dis, Fukuoka, Japan
[13] Kumamoto Municipal Hosp, Kumamoto, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e13005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13005
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin
    Meng-Xia Su
    Hsiang-Wen Lin
    Hanh T. H. Nguyen
    Tien-Chao Lin
    Chih-Jung Chen
    Hwei-Chung Wang
    Chen-Teng Wu
    Yao-Chung Wu
    Geng-Yan He
    Liang-Chih Liu
    Chih-Hao Huang
    BMC Cancer, 24
  • [2] Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin
    Su, Meng-Xia
    Lin, Hsiang-Wen
    Nguyen, Hanh T. H.
    Lin, Tien-Chao
    Chen, Chih-Jung
    Wang, Hwei-Chung
    Wu, Chen-Teng
    Wu, Yao-Chung
    He, Geng-Yan
    Liu, Liang-Chih
    Huang, Chih-Hao
    BMC CANCER, 2024, 24 (01)
  • [3] Neutrophil to lymphocyte ratio (NLR) may predict survival and efficacy of eribulin in advanced breast cancer patients
    Haruyama, Y.
    Fukuma, E.
    Yu, O.
    Koshida, Y.
    Sakamoto, N.
    Gen, A.
    Nakagawa, R.
    Nashimoto, M.
    Sakamoto, M.
    Teraoka, K.
    Nakagawa, M.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S64 - S65
  • [4] The prognostic and predictive roles of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in HER2-negative metastatic breast cancer patients treated with paclitaxel-bevacizumab
    Hayashi, Tomomi
    Watanabe, Junichiro
    Nakamoto, Shyogo
    CANCER RESEARCH, 2020, 80 (04)
  • [5] Trends of Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio across Times among Breast Cancer Patients using Eribulin
    Su, M. X.
    Lin, H. W.
    Nguyen, H. T. H.
    Lin, T. C.
    Chen, C. J.
    Wang, H. C.
    Wu, C. T.
    Wu, Y. C.
    He, G. Y.
    Liu, L. C.
    Huang, C. H.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 51 - 51
  • [6] Survival benefit of eribulin for metastatic breast cancer depends on absolute lymphocyte count and neutrophil-lymphocyte ratio in peripheral blood
    Ueno, Ayako
    Ohtani, Shoichiro
    Kawasaki, Kensuke
    Ito, Mitsuya
    Kin, Takanori
    Maeda, Reina
    CANCER RESEARCH, 2020, 80 (04)
  • [7] C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin
    Sata, Atsushi
    Fukui, Reiko
    Miyagawa, Yoshimasa
    Bun, Ayako
    Ozawa, Hiromi
    Fujimoto, Yukie
    Higuchi, Tomoko
    Imamura, Michiko
    Miyoshi, Yasuo
    ANTICANCER RESEARCH, 2020, 40 (07) : 4147 - 4156
  • [8] Association of Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count with Clinical Outcomes for Patients with Advanced Breast Cancer in the MONARCH 2 Trial
    Tokunaga, Eriko
    Miyoshi, Yasuo
    Dozono, Koji
    Kawaguchi, Tsutomu
    Toi, Masakazu
    CANCER RESEARCH, 2023, 83 (05)
  • [9] Pretreatment Absolute Lymphocyte Count and Neutrophil-to-lymphocyte Ratio Are Prognostic Factors for Stage III Breast Cancer
    Yamanouchi, Kosho
    Maeda, Shigeto
    Takei, Daiki
    Koga, Yoichi
    Yamashita, Manpei
    Hamada, Takashi
    Hirayama, Takanori
    Yoneda, Akira
    Tokunaga, Takayuki
    Takeshita, Hiroaki
    Kuroki, Tamotsu
    ANTICANCER RESEARCH, 2021, 41 (07) : 3625 - 3634
  • [10] Utility of the Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio for Predicting Survival in Patients with Metastatic Breast Cancer on Eribulin: A Real-World Observational Study
    Ueno, Ayako
    Maeda, Reina
    Kin, Takanori
    Ito, Mitsuya
    Kawasaki, Kensuke
    Ohtani, Shoichiro
    CHEMOTHERAPY, 2020, 64 (5-6) : 259 - 269
12345